Hyperthermic Intraperitoneal Chemotherapy–Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer

Hyperthermic intraperitoneal chemotherapy (HIPEC) confers a survival benefit in epithelial ovarian cancer (EOC) and in preclinical models. However, the molecular changes induced by HIPEC have not been corroborated in humans. PATIENTS AND METHODS: A feasibility trial evaluated clinical and safety out...

Descripción completa

Detalles Bibliográficos
Autores principales: Dellinger, Thanh H., Han, Ernest S., Raoof, Mustafa, Lee, Byrne, Wu, Xiwei, Cho, Hyejin, He, Ting-Fang, Lee, Peter, Razavi, Marianne, Liang, Winnie S., Schmolze, Daniel, Priceman, Saul J., Lee, Stephen, Lin, Wei-Chien, Lin, Jeff F., Kebria, Mehdi, Hakim, Amy, Ruel, Nora, Stewart, Daphne B., Wang, Edward W., Paz, Benjamin I., Wakabayashi, Mark T., Cristea, Mihaela C., Rodriguez-Rodriguez, Lorna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984280/
https://www.ncbi.nlm.nih.gov/pubmed/35357903
http://dx.doi.org/10.1200/PO.21.00239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984280/
https://www.ncbi.nlm.nih.gov/pubmed/35357903
http://dx.doi.org/10.1200/PO.21.00239

Ejemplares similares